中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2013年
7期
29-31
,共3页
孙广范%林霞%陈源%尚雪
孫廣範%林霞%陳源%尚雪
손엄범%림하%진원%상설
子宫动脉%急性大出血%妇科%动脉栓塞
子宮動脈%急性大齣血%婦科%動脈栓塞
자궁동맥%급성대출혈%부과%동맥전새
Uterine artery%Acute hemorrhage%Gynecology%Arterial embolization
目的 探讨超选择动脉栓塞术在治疗妇科急性子宫大出血中的临床价值.方法 对中山市博爱医院2008年10月至2011年10月期间发生的妇科急性子宫大出血患者18例行经皮穿刺股动脉插管,超选择双侧子宫动脉栓塞.结果 18例患者术后阴道大出血立即停止,有少量或无阴道出血,止血有效率达100%.术后仅有低热、下腹及臀部疼痛等轻微并发症.结论 超选择动脉栓塞治疗妇科急性子宫大出血创伤小、止血快、疗效明显、安全、不良反应少;同时能对患者进行介入化疗,可以有效提升局部药物浓度又延长药物作用时间,降低化疗药物全身的不良反应,作为治疗子宫大出血的一种微创手术,可在临床上广泛推广应用.
目的 探討超選擇動脈栓塞術在治療婦科急性子宮大齣血中的臨床價值.方法 對中山市博愛醫院2008年10月至2011年10月期間髮生的婦科急性子宮大齣血患者18例行經皮穿刺股動脈插管,超選擇雙側子宮動脈栓塞.結果 18例患者術後陰道大齣血立即停止,有少量或無陰道齣血,止血有效率達100%.術後僅有低熱、下腹及臀部疼痛等輕微併髮癥.結論 超選擇動脈栓塞治療婦科急性子宮大齣血創傷小、止血快、療效明顯、安全、不良反應少;同時能對患者進行介入化療,可以有效提升跼部藥物濃度又延長藥物作用時間,降低化療藥物全身的不良反應,作為治療子宮大齣血的一種微創手術,可在臨床上廣汎推廣應用.
목적 탐토초선택동맥전새술재치료부과급성자궁대출혈중적림상개치.방법 대중산시박애의원2008년10월지2011년10월기간발생적부과급성자궁대출혈환자18례행경피천자고동맥삽관,초선택쌍측자궁동맥전새.결과 18례환자술후음도대출혈립즉정지,유소량혹무음도출혈,지혈유효솔체100%.술후부유저열、하복급둔부동통등경미병발증.결론 초선택동맥전새치료부과급성자궁대출혈창상소、지혈쾌、료효명현、안전、불량반응소;동시능대환자진행개입화료,가이유효제승국부약물농도우연장약물작용시간,강저화료약물전신적불량반응,작위치료자궁대출혈적일충미창수술,가재림상상엄범추엄응용.
Objective To investigate the clinical value of superselective arterial embolization on gynecological acute uterine hemorrhage disease.Methods Percutaneous femoral artery catheterization and uterine artery embolization were performed in 18 patients with gynecological acute uterine hemorrhage diseases in Boai hospital from October 2008 to October 2011.Results The massive vaginal bleeding stopped after operation immediately,the immediate hemostatic rate was 100%,with or without fewer vaginal bleeding.Only some minor complications such as low-grade fever,mild abdominal and hip pain were ocurred.Conclusions Superselective arterial embolization for the treatment of gynecological acute uterine hemorrhage diseases is safe and effective which has the advantages of minimal trauma,fast homeostasis,less complication.Meanwhile,the patients can accept interventional chemotherapy,which effectively enhance the local drug concentration and prolong drug duration of action and reduce systemic adverse reactions of chemotherapy drugs.It can be deserving the clinical application as a minimally invasive treatment of uterine hemorrhage diseases.